Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Medical and Biological Research |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000300237 |
Resumo: | Studies have indicated that early-life or early-onset depression is associated with a 2- to 4-fold increased risk of developing Alzheimers disease (AD). In AD, aggregation of an abnormally phosphorylated form of the tau protein may be a key pathological event. Tau is known to play a major role in promoting microtubule assembly and stabilization, and in maintaining the normal morphology of neurons. Several studies have reported that stress may induce tau phosphorylation. The main aim of the present study was to investigate possible alterations in the tau protein in the hippocampus and frontal cortex of 32 male Sprague-Dawley rats exposed to chronic unpredictable mild stress (CUMS) and then re-exposed to CUMS to mimic depression and the recurrence of depression, respectively, in humans. We evaluated the effects of CUMS, fluoxetine, and CUMS re-exposure on tau and phospho-tau. Our results showed that a single exposure to CUMS caused a significant reduction in sucrose preference, indicating a state of anhedonia. The change in behavior was accompanied by specific alterations in phospho-tau protein levels, but fluoxetine treatment reversed the CUMS-induced impairments. Moreover, changes in sucrose preference and phospho-tau were more pronounced in rats re-exposed to CUMS than in those subjected to a single exposure. Our results suggest that changes in tau phosphorylation may contribute to the link between depression and AD. |
id |
ABDC-1_d558baadf58d80e9e2194b5bdf87a4c6 |
---|---|
oai_identifier_str |
oai:scielo:S0100-879X2014000300237 |
network_acronym_str |
ABDC-1 |
network_name_str |
Brazilian Journal of Medical and Biological Research |
repository_id_str |
|
spelling |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stressAlzheimers diseaseDepressionTauChronic unpredictable mild stress (CUMS)Re-exposure to CUMSFluoxetineStudies have indicated that early-life or early-onset depression is associated with a 2- to 4-fold increased risk of developing Alzheimers disease (AD). In AD, aggregation of an abnormally phosphorylated form of the tau protein may be a key pathological event. Tau is known to play a major role in promoting microtubule assembly and stabilization, and in maintaining the normal morphology of neurons. Several studies have reported that stress may induce tau phosphorylation. The main aim of the present study was to investigate possible alterations in the tau protein in the hippocampus and frontal cortex of 32 male Sprague-Dawley rats exposed to chronic unpredictable mild stress (CUMS) and then re-exposed to CUMS to mimic depression and the recurrence of depression, respectively, in humans. We evaluated the effects of CUMS, fluoxetine, and CUMS re-exposure on tau and phospho-tau. Our results showed that a single exposure to CUMS caused a significant reduction in sucrose preference, indicating a state of anhedonia. The change in behavior was accompanied by specific alterations in phospho-tau protein levels, but fluoxetine treatment reversed the CUMS-induced impairments. Moreover, changes in sucrose preference and phospho-tau were more pronounced in rats re-exposed to CUMS than in those subjected to a single exposure. Our results suggest that changes in tau phosphorylation may contribute to the link between depression and AD.Associação Brasileira de Divulgação Científica2014-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000300237Brazilian Journal of Medical and Biological Research v.47 n.3 2014reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431X20133275info:eu-repo/semantics/openAccessYang,C.Guo,X.Wang,G.H.Wang,H.L.Liu,Z.C.Liu,H.Zhu,Z.X.Li,Y.eng2015-09-04T00:00:00Zoai:scielo:S0100-879X2014000300237Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2015-09-04T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false |
dc.title.none.fl_str_mv |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
title |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
spellingShingle |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress Yang,C. Alzheimers disease Depression Tau Chronic unpredictable mild stress (CUMS) Re-exposure to CUMS Fluoxetine |
title_short |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
title_full |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
title_fullStr |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
title_full_unstemmed |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
title_sort |
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress |
author |
Yang,C. |
author_facet |
Yang,C. Guo,X. Wang,G.H. Wang,H.L. Liu,Z.C. Liu,H. Zhu,Z.X. Li,Y. |
author_role |
author |
author2 |
Guo,X. Wang,G.H. Wang,H.L. Liu,Z.C. Liu,H. Zhu,Z.X. Li,Y. |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Yang,C. Guo,X. Wang,G.H. Wang,H.L. Liu,Z.C. Liu,H. Zhu,Z.X. Li,Y. |
dc.subject.por.fl_str_mv |
Alzheimers disease Depression Tau Chronic unpredictable mild stress (CUMS) Re-exposure to CUMS Fluoxetine |
topic |
Alzheimers disease Depression Tau Chronic unpredictable mild stress (CUMS) Re-exposure to CUMS Fluoxetine |
description |
Studies have indicated that early-life or early-onset depression is associated with a 2- to 4-fold increased risk of developing Alzheimers disease (AD). In AD, aggregation of an abnormally phosphorylated form of the tau protein may be a key pathological event. Tau is known to play a major role in promoting microtubule assembly and stabilization, and in maintaining the normal morphology of neurons. Several studies have reported that stress may induce tau phosphorylation. The main aim of the present study was to investigate possible alterations in the tau protein in the hippocampus and frontal cortex of 32 male Sprague-Dawley rats exposed to chronic unpredictable mild stress (CUMS) and then re-exposed to CUMS to mimic depression and the recurrence of depression, respectively, in humans. We evaluated the effects of CUMS, fluoxetine, and CUMS re-exposure on tau and phospho-tau. Our results showed that a single exposure to CUMS caused a significant reduction in sucrose preference, indicating a state of anhedonia. The change in behavior was accompanied by specific alterations in phospho-tau protein levels, but fluoxetine treatment reversed the CUMS-induced impairments. Moreover, changes in sucrose preference and phospho-tau were more pronounced in rats re-exposed to CUMS than in those subjected to a single exposure. Our results suggest that changes in tau phosphorylation may contribute to the link between depression and AD. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000300237 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000300237 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1414-431X20133275 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research v.47 n.3 2014 reponame:Brazilian Journal of Medical and Biological Research instname:Associação Brasileira de Divulgação Científica (ABDC) instacron:ABDC |
instname_str |
Associação Brasileira de Divulgação Científica (ABDC) |
instacron_str |
ABDC |
institution |
ABDC |
reponame_str |
Brazilian Journal of Medical and Biological Research |
collection |
Brazilian Journal of Medical and Biological Research |
repository.name.fl_str_mv |
Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC) |
repository.mail.fl_str_mv |
bjournal@terra.com.br||bjournal@terra.com.br |
_version_ |
1754302943269486592 |